Coronavirüs Enfeksiyonu Hastalığının (COVID-19) Epidemiyolojisi ve Kontrolü

Year 2020, Volume: 5 Issue: 2, 109 - 116, 30.06.2020

Ayşe Akbıyık , Özlem Avşar

Abstract

Özet

Aralık 2019’da Çin’in Wuhan şehrinde, deniz ürünleri pazarı kaynaklı yeni bir coronavirüs çeşidi kısa sürede pandemi haline gelmiş ve tüm ülkelerin ortak problemi olmuştur. Şiddetli Akut Solunum Sendromu Coronavirüs-2 tek zincirli, pozitif polariteli, zarflı, ribonükleik asit virüsüdür. COVID-19 solunum sistemini hedef almaktadır ve insandan insana bulaşma damlacık yoluyla gerçekleşmektedir. Virüsün cansız yüzeylerde sağ kalımını sürdürebilmesi temas yoluyla da bulaşmayı mümkün kılmaktadır. Hastalığın belirtileri arasında ateş, nefes darlığı, öksürük yer almaktadır. Olguların çoğunda hafif semptomlar görülse de, pnömoni, akut solunum sıkıntısı sendromu, çoklu organ yetmezliği ve ölümü gibi ağır seyirli klinik durumlar da mevcuttur. Maske kullanımı, sosyal mesafe ve el yıkama COVID-19 salgınının önlenmesinde anahtar rol oynamaktadır. Yeni tanınmaya başlanan bu enfeksiyon hakkında hala çok şey öğrenilmesi gerekmektedir.

Anahtar Kelimeler: Coronavirüs, COVID-19, pandemi,epidemiyoloji.

Abstract

In December 2019, a novel coronavirus originating from a seafood market in Wuhan, China became a pandemic in a short time and a common problem for all countries. Severe Acute Respiratory Syndrome Coronavirus 2 is a single-chain, positive polarity, and enveloped ribonucleic acid virus. COVID-19 targets the respiratory system and humanto-human transmission occurs by inhalation of respiratory droplets. The virus’s survival on inanimate surfaces also makes it possible to be transmitted by contact. Symptoms of the disease include fever, shortness of breath, and cough. Although mild symptoms are present in the majority of the cases, there are also severe clinical conditions such as pneumonia, acute respiratory distress syndrome, multiple organ failure, and death. Mask use, social distancing, and hand-washing play a key role in preventing the spread of COVID-19. Much still needs to be learned about this newly recognized infection.

Keywords: Coronavirus, COVID-19, pandemic, epidemiology.

Keywords

Coronavirüs, Pandemi, epidemiyoloji, COVID-19

Epidemiology and Control of Coronavirus Infection Disease (COVID-19)

Abstract

Keywords

Coronavirus, COVID-19, Pandemic

References

• Akbaba, M., Kurt, B., & Nazlıcan, E. (2014). Yeni Coronavirus salgını: MERS-CoV. Türkiye Halk Sağlığı Dergisi, 12(3), 217.
• Angeletti, S., Benvenuto, D., Bianchi, M., Giovanetti, M., Pascarella, S., & Ciccozzi, M. (2020). COVID-2019: The role of the nsp2 and nsp3 in its pathogenesis. Journal of Medical Virology, 92(6), 584–588.
• Cascella, M., Rajnik, M., Cuomo, A., Dulebohn, S. C., & Di Napoli, R. (2020). Features, evaluation and treatment Coronavirus (COVID-19). StatPearls, from http://www.ncbi.nlm.nih.gov/pubmed/32150360. Erişim tarihi: 07.05.2020.
• Chan, J. F. W., Kok, K. H., Zhu, Z., Chu, H., To, K. K. W., Yuan, S., & Yuen, K. Y. (2020). Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerging Microbes and Infections, 9(1), 221–236.
• Chan, J. F. W., To, K. K. W., Tse, H., Jin, D. Y., & Yuen, K. Y. (2013). interspecies transmission and emergence of novel viruses: lessons from bats and birds. Trends in Microbiology, 21(10), 544–555.
• Garg, S., Kim, L., Whitaker, M., O’Halloran, A., Cummings, C., Holstein, R., et al (2020). Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed Coronavirus disease 2019 - COVIDNET, 14 States, March 1-30, 2020. Morbidity and Mortality Weekly Report, 69(15):458-464.
• Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., et al. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, 395(10223), 497–506.
• Lei, J., Kusov, Y., & Hilgenfeld, R. (2020). Since January 2020 elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- 19. The COVID-19 resource centre is hosted on Elsevier Connect , the company ’ s public news and information. Antiviral Research, 149(January), 58–74.
• Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., et al. (2020). Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. New England Journal of Medicine, 382(13), 1199–1207.
• Lu, H. (2015). Drug treatment options for the 2019-new coronavirus (2019- nCoV). BioScience Trends Advance Publication, 176–185.
• Mcintosh K. (2020). Coronavirus disease 2019 (COVID-19), UpToDate, from https:// www.uptodate.com/contents/coronavirus-disease-2019-covid-19. Erişim tarihi: 10.05.2020.
• McMichael, T.M., Currie, D.W., Clark, S., Pogosjans S., Kay, M., Schwartz, N.G., et al. (2020). Epidemiology of Covid-19 in a long-term care facility in King County, Washington. New England Journal of Medicine.
• Nishiura, H., Jung, S., Linton, N. M., Kinoshita, R., Yang, Y., Hayashi, K., et al. (2020). The extent of transmission of Novel Coronavirus in Wuhan, China, 2020. Journal of Clinical Medicine, 9(2), 330.
• Ren, L. L., Wang, Y. M., Wu, Z. Q., Xiang, Z. C., Guo, L., Xu, T., et al. (2020). Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chinese Medical Journal, 4–13.
• Rothan, H. A., & Byrareddy, S. N. (2020). The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Journal of Autoimmunity, 109(February), 102433.
• Toots, M., Yoon, J. J., Cox, R. M., Hart, M., Sticher, Z. M., Makhsous, N., et al. (2019). Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia. Science Translational Medicine, 11(515), 1–14.
• Türkiye Cumhuriyeti Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü. (2020). COVID-19 rehberi. COVID-19 Rehberi, 2 Nisan 20, 25.
• Velavan, T. P., & Meyer, C. G. (2020). The COVID-19 epidemic. Tropical Medicine and International Health, 25(3), 278–280.
• Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., et al. (2020). Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Research, 30(3), 269–271.
• Wang, W., Tang, J., & Wei, F. (2020). Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China. Journal of Medical Virology, 92(4), 441–447.
• World Health Organization. (2020). Coronavirus disease 2019 (COVID-19) situation report - 16-24 Şubat 2020. Coronovirus Disease 2019 (COVID-19) Situation Report, 16-24 Şubat 2020, from https://www.who.int/ docs/default-source/coronaviruse/situation-reports/20200217-sitrep-28-covid-19.pdf?sfvrsn=a19cf2ad_2. Erişim tarihi: 13.05.2020.
• Zhao, S., Lin, Q., Ran, J., Musa, S. S., Yang, G., Wang, W., et al. (2020). Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak. International Journal of Infectious Diseases, 92, 214–217.